Chinese expert consensus on clinical application of recombinant oncolytic adenovirus in the treatment of malignant tumors
Treatment using oncolytic virus as a new tumor immunologic agent has made continuous breakthroughs in basic and clinical research of tumor in recent years, and it is expected to play an important role in cancer immunotherapy in the future. At present, there are 4 oncolytic viruses approved for marke...
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Artikkeli |
| Kieli: | English |
| Julkaistu: |
Editorial Office of China Oncology
2023-05-01
|
| Sarja: | Zhongguo aizheng zazhi |
| Aiheet: | |
| Linkit: | http://www.china-oncology.com/fileup/1007-3639/PDF/1686896465477-1251193185.pdf |